Literature DB >> 7724541

Crystallization and preliminary x-ray studies of NADPH-cytochrome P450 reductase.

S Djordjevic1, D L Roberts, M Wang, T Shea, M G Camitta, B S Masters, J J Kim.   

Abstract

NADPH-cytochrome P450 reductase (CPR; NADPH:ferrihemoprotein reductase, EC 1.6.2.4) catalyzes the transfer of electrons to all known microsomal cytochromes P450. CPR is unique in that it is one of only two mammalian enzymes known to contain both flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN), the other being the various isoforms of nitric oxide synthase. Similarities in amino acid sequence and in functional domain arrangement with other key flavoproteins, including nitric oxide synthase, make CPR an excellent prototype for studies of interactions between two flavin cofactors. We have obtained diffraction-quality crystals of rat liver CPR, expressed in Escherichia coli and solubilized by limited proteolysis with trypsin. The crystals were grown in Hepes buffer (pH 7.0), containing polyethylene glycol 4500 and NaCl. The crystals belong to the orthorhombic space group P2(1)2(1)2(1), with unit cell dimensions a = 103.3 A, b = 116.1 A, and c = 120.4 A. If we assume that there are two molecules of the 72-kDa CPR polypeptide per asymmetric unit, the calculated value of Vm is 2.54 A3/Da.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7724541      PMCID: PMC42136          DOI: 10.1073/pnas.92.8.3214

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Molecular cloning and sequence analysis of full-length cDNA for rabbit liver NADPH-cytochrome P-450 reductase mRNA.

Authors:  M Katagiri; H Murakami; Y Yabusaki; T Sugiyama; M Okamoto; T Yamano; H Ohkawa
Journal:  J Biochem       Date:  1986-10       Impact factor: 3.387

2.  Time-resolved fluorescence spectroscopy of NADPH-cytochrome P-450 reductase: demonstration of energy transfer between the two prosthetic groups.

Authors:  P I Bastiaens; P J Bonants; F Müller; A J Visser
Journal:  Biochemistry       Date:  1989-10-17       Impact factor: 3.162

3.  Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis.

Authors:  A L Shen; T D Porter; T E Wilson; C B Kasper
Journal:  J Biol Chem       Date:  1989-05-05       Impact factor: 5.157

4.  A 31P-nuclear-magnetic-resonance study of NADPH-cytochrome-P-450 reductase and of the Azotobacter flavodoxin/ferredoxin-NADP+ reductase complex.

Authors:  P J Bonants; F Müller; J Vervoort; D E Edmondson
Journal:  Eur J Biochem       Date:  1990-07-05

5.  Expression and secretion of foreign proteins in Escherichia coli.

Authors:  G D Duffaud; P E March; M Inouye
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

6.  Structural comparison between the trout and mammalian hydrophilic domain of NADPH-cytochrome P-450 reductase.

Authors:  J Urenjak; D Linder; L Lumper
Journal:  J Chromatogr       Date:  1987-06-26

7.  Human NADPH-P450 oxidoreductase: complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7.

Authors:  S Yamano; T Aoyama; O W McBride; J P Hardwick; H V Gelboin; F J Gonzalez
Journal:  Mol Pharmacol       Date:  1989-07       Impact factor: 4.436

8.  Expression of a functional 78,000 dalton mammalian flavoprotein, NADPH-cytochrome P-450 oxidoreductase, in Escherichia coli.

Authors:  T D Porter; T E Wilson; C B Kasper
Journal:  Arch Biochem Biophys       Date:  1987-04       Impact factor: 4.013

9.  Structural and functional analysis of NADPH-cytochrome P-450 reductase from human liver: complete sequence of human enzyme and NADPH-binding sites.

Authors:  M Haniu; M E McManus; D J Birkett; T D Lee; J E Shively
Journal:  Biochemistry       Date:  1989-10-17       Impact factor: 3.162

10.  Primary structure of Saccharomyces cerevisiae NADPH-cytochrome P450 reductase deduced from nucleotide sequence of its cloned gene.

Authors:  Y Yabusaki; H Murakami; H Ohkawa
Journal:  J Biochem       Date:  1988-06       Impact factor: 3.387

View more
  6 in total

1.  Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes.

Authors:  M Wang; D L Roberts; R Paschke; T M Shea; B S Masters; J J Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

2.  Redox cycling and increased oxygen utilization contribute to diquat-induced oxidative stress and cytotoxicity in Chinese hamster ovary cells overexpressing NADPH-cytochrome P450 reductase.

Authors:  Karma C Fussell; Ronald G Udasin; Joshua P Gray; Vladimir Mishin; Peter J S Smith; Diane E Heck; Jeffrey D Laskin
Journal:  Free Radic Biol Med       Date:  2011-01-04       Impact factor: 7.376

3.  1H, 15N and 13C NMR resonance assignment, secondary structure and global fold of the FMN-binding domain of human cytochrome P450 reductase.

Authors:  I Barsukov; S Modi; L Y Lian; K H Sze; M J Paine; C R Wolf; G C Roberts
Journal:  J Biomol NMR       Date:  1997-07       Impact factor: 2.835

Review 4.  Role of protein-protein interactions in cytochrome P450-mediated drug metabolism and toxicity.

Authors:  Sylvie E Kandel; Jed N Lampe
Journal:  Chem Res Toxicol       Date:  2014-08-29       Impact factor: 3.739

5.  Structural Dynamics of Cytochrome P450 3A4 in the Presence of Substrates and Cytochrome P450 Reductase.

Authors:  Julie Ducharme; Irina F Sevrioukova; Christopher J Thibodeaux; Karine Auclair
Journal:  Biochemistry       Date:  2021-07-01       Impact factor: 3.321

6.  Cytochrome P450 CYP1B1 activity in renal cell carcinoma.

Authors:  M C E McFadyen; W T Melvin; G I Murray
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.